Rabia Shahswar

4PUBLICATIONS
34CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Katja Krüger, Razif Gabdoulline, Martin Wichmann

|Mar 09, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.

Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders

|Jul 25, 2020
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up.

Rabia Shahswar, Gernot Beutel, Razif Gabdoulline

|Nov 05, 2019
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.

Rabia Shahswar, Gernot Beutel, Piroska Klement

Pageof 1

Frequent Collaborators

2 joint publications

Michael Heuser

2 joint publications

Christoph Röllig

1 joint publications

Alexander Waclawiczek

1 joint publications

Aino-Maija Leppä